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Abstract
Background: Post-myocardial infarction (MI) structural remodeling is characterized by left ventricular dilatation, fibrosis, and
hypertrophy of the non-infarcted myocardium.
Objective: The goal of our study was to quantify post-MI electrical remodeling by measuring the sum absolute QRST
integral (SAI QRST). We hypothesized that adverse electrical remodeling predicts outcomes in MADIT II study participants.
Methods: Baseline orthogonal ECGs of 750 MADIT II study participants (448 [59.7%] ICD arm) were analyzed. SAI QRST was
measured as the arithmetic sum of absolute QRST integrals over all three orthogonal ECG leads. The primary endpoint was
defined as sudden cardiac death (SCD) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate
ICD therapies. All-cause mortality served as a secondary endpoint.
Results: Adverse electrical remodeling in post-MI patients was characterized by wide QRS, increased magnitudes of spatial
QRS and T vectors, J-point deviation, and QTc prolongation. In multivariable Cox regression analysis after adjustment for
age, QRS duration, atrial fibrillation, New York Heart Association heart failure class and blood urea nitrogen, SAI QRST
predicted SCD/VT/VF (HR 1.33 per 100 mV*ms (95%CI 1.11–1.59); P = 0.002), and all-cause death (HR 1.27 per 100 mV*ms
(95%CI 1.03–1.55), P = 0.022) in both arms. No interaction with therapy arm and bundle branch block (BBB) status was
found.
Conclusions: In MADIT II patients, increased SAI QRST is associated with increased risk of sustained VT/VF with appropriate
ICD therapies and all-cause death in both ICD and in conventional medical therapy arms, and in patients with and without
BBB. Further studies of SAI QRST are warranted.
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Introduction
Electrical and structural remodeling is a continuous process that
begins early after myocardial infarction (MI), and ventricular
arrhythmias occur late in the remodeling manifestation [1,2]. Post-
infarction structural remodeling is well described [3] and is
characterized by scar formation [4] in the central and border zone
areas [5], progressive dilatation and distortion of cavity shape,
progressive vasculopathy due to activation of the neurohumoral
pathways, left ventricular (LV) dysfunction, fibrosis, and hyper-
trophy of non-infarcted myocardium [6,7].
ECG signs of post-MI scar (deep and broad Q wave, QS waves,
fragmented QRS, bundle branch block [BBB], fascicular block)
are well known. It is known that post-MI scar ECG features can
change over time, e.g. Q waves may resolve within one year post-
MI [8]. However, complete ECG manifestations of post-MI
electrical remodeling are not entirely understood. LV hypertrophy
is recognized as a strong risk factor of ventricular arrhythmias
[9,10]. ECG marker of LV hypertrophy, Cornell voltage-duration
product, was shown to be associated with the risk of sudden
cardiac death (SCD) [11–13]. In hypertrophic cardiomyopathy
patients, large sum of the 12-lead QRS-amplitudes predicted
sudden cardiac arrest [14]. Adverse post-MI remodeling is
characterized [15] by the progressive apoptotic loss of cardiomy-
ocytes in areas remote from the scar location, insufficient
pathological hypertrophy and thereby ventricular wall thinning
and fibrosis, and progressive LV dilatation [6]. More favorable
post-MI remodeling is characterized by an inhibition of post-MI
fibrosis, removal of excess collagen, and compensatory hypertro-
phy with adequate angiogenesis in the remote myocardium [16].
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However, distinct ECG characteristics of adverse post-MI
remodeling, in comparison to more favorable post-MI remodeling
have not been systematically described. Moreover, presence of
bundle branch block (BBB) on ECG significantly limits interpre-
tation and prognostic value of ECG, and to date, no reliable ECG
marker of electrical remodeling in BBB has been developed.
Electrical remodeling involves both depolarization and repolar-
ization phases of the cardiac cycle, which should be taken into
account in order to quantify post-MI electrical remodeling.
Recently we developed a novel ECG marker, associated with
the risk of ventricular arrhythmias in primary prevention ICD
patients [17,18]. We hypothesized that our new marker, sum
absolute QRST integral (SAI QRST), as a marker of adverse
electrical remodeling, predicts SCD and sustained ventricular
tachycardia (VT)/ventricular fibrillation (VF) with appropriate
ICD therapies in post-MI patients with systolic dysfunction,
participants of the landmark MADIT II ICD trial, in both arms
(ICD and conventional medical therapy), both in patients with and
without BBB.
Methods
MADIT II Study Population
The post hoc analysis presented in this manuscript was
performed using prospectively collected data of the MADIT II
trial. Design and results of the MADIT II study are well-described
[19,20]. Baseline 10-minute high resolution (sampling rate
1000 Hz and amplitude resolution 0.1526 mV) orthogonal ECGs
were recorded at rest via digital Spacelab-Burdick 6632 Holter
recorders (Spacelab-Burdick, Milton, WI) [19,21]. We analyzed
data of participants with available 10-minute ECGs in both the
ICD arm and in the conventional medical therapy arm. The
original MADIT II trial 4-year (median 20 months) period of
follow-up was included in our analysis. Combined endpoint,
defined as either SCD or sustained VT/VF with appropriate ICD
therapies served as the primary end point in our study. Total
mortality served as a secondary end-point.
Sum Absolute QRST Integral Measurement
Baseline ECG analysis was performed by investigators fully
blinded to the study outcomes and patients clinical characteristics
(L.H., L.G.T.). Customized MATLAB (MathWorks, Inc., Natick,
MA) software application for data analysis was developed in
Tereshchenko’s laboratory. Noisy recordings were excluded from
analysis. ECG recordings in atrial flutter and atrial fibrillation with
large visible f-waves were excluded, whereas those with atrial
fibrillation and small f-waves were analyzed if f-waves did not
preclude precise Tend detection. ECG recordings with conduction
abnormalities (AV block, BBB) were analyzed. Premature
ventricular contraction (PVC) beats and one consecutive sinus
beat after PVC were excluded. ECG recordings with frequent
Table 1. Baseline clinical characteristics of patients with SAI QRST, dichotomized at the 75th percentile (.334 mV*ms).
SAI QRST Q1-Q3 (n = 562) SAI QRST Q4 (n = 188) P
Missing, n % Missing, n %
Age $65 y 0 41.0 57.8 ,0.001
Female 0 16.9 0 21.4 0.164
NYHA class II-IV 7 61.2 2 68.1 0.090
EF ,25% 0 41.6 0 56.7 ,0.001
BMI $30 0 36.1 0 23.0 0.001
QRS .120 ms 4 15.4 3 68.5 ,0.001
LBBB 7 3.6 4 55.7 ,0.001
RBBB 7 6.7 4 4.9 0.399
HR. = 80 bpm 8 24.5 3 31.0 0.083
CABG 0 52.6 0 61.0 0.046
non-CABG revasc 8 47.2 1 34.4 0.002
MI ,18 months 37 70.3 7 77.8 0.055
BUN .25 mg/dL 5 22.6 1 29.6 0.054
Creatinine $1.4 (Q4) 2 20.1 0 26.2 0.081
Diabetes mellitus 1 34.7 0 30.5 0.291
Treatment (ICD arm) 0 61.1 0 55.6 0.185
Inducible VT narrow defin 294 34.6 99 34.1 0.934
Beta-blockers 0 68.4 0 54.0 0.0001
Calcium ch block 0 12.3 0 19.3 0.017
ACE-I 0 79.2 0 77.5 0.627
ARBs 0 11.5 0 16.6 0.074
Amiodarone 0 6.0 0 5.3 0.727
Class I AA 0 2.5 0 5.3 0.110
Diuretics 0 69.4 0 80.2 0.005
Digitalis 0 54.7 0 62.0 0.080
doi:10.1371/journal.pone.0051812.t001
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PVCs (bigeminy, trigeminy), as well as ventricular-paced rhythm,
were excluded. Fiducial points [beginning of Q or R wave and end
of T wave] were detected automatically on XYZ leads by
previously described methods [22], [23]. The accuracy of the
automatically detected fiducial points on each beat was visually
checked by investigators (L.H., L.G.T.). The ‘‘zero’’ value of the
Table 2. Outcomes and baseline ECG parameters in patients with SAI QRST, dichotomized at the 75th percentile (.334 mV*ms).
SAI QRST Q1–Q3 (n = 562) SAI QRST Q4 (n = 188) P
Missing, n Mean, % Missing, n Mean, %
ICD therapy for VT/VF 229 20.1 85 36.3 0.001
All-cause death 0 11.4 0 19.3 0.006
CHF hospitalization 2 15.9 2 22.2 0.050
CHF hosp or death 2 21.9 2 31.9 0.006
ReMI hospitalization 2 3.4 1 3.2 0.916
Cardiac death 2 8.9 1 17.7 0.001
SCD 5 5.7 7 8.9 0.136
Non-sudden cardiac death 5 2.7 7 6.1 0.030
QTc 6SD, ms 467635 492641 ,0.0001
Mean heart rate6SD, bpm 68.1613.9 71.8613.4 0.001
QRS duration6SD, ms 114.4613.8 166.2622.5 ,0.0001
Spatial QRS vector magnitude6SD, mV 2.1960.65 3.1960.82 ,0.0001
Spatial T vector magnitude6SD, mV 0.3560.17 0.8160.36 ,0.0001
Interloop distance6SD, mV 0.02560.026 0.06960.070 ,0.0001
doi:10.1371/journal.pone.0051812.t002
Figure 1. Correlations between QRS width and SAI QRST (A), between mean magnitude of spatial QRS vector and SAI QRST (B),
between mean magnitude of spatial T vector and SAI QRST (C), and between mean heart rate and SAI QRST (D). Linear regression
fitted line is shown in each graph.
doi:10.1371/journal.pone.0051812.g001
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baseline was determined by the position of the T end [23].
Trapezoidal Riemann sums (1 ms interval size) were used to
calculate the area under the QRST curve. Absolute QRST
integral was measured as the arithmetic sum of areas under the
QRST curve, averaged during a 3-minute epoch. The sum
magnitude of three orthogonal leads absolute QRST integral (SAI











Magnitude of spatial QRS vector and magnitude of spatial T
vectors were measured as previously described [24]. J-point
deviation was measured as interloop distance metric the shortest
distance between QRS and T loops as previously described [25].
Statistical Analysis
Statistical analysis was performed in the Statistical Core
Laboratory of the Heart Research Follow-up Program at the
University of Rochester. Normally distributed continuous vari-
ables were compared using the independent samples t test, and
results are presented as mean6standard deviation (SD). Categor-
ical variables were compared using Pearson’s chi-square test. SAI
QRST distribution was categorized by quartiles. SAI QRST was
regressed on QRS width, mean magnitude of spatial QRS and T
vectors, 3D J-point deviation amplitude (interloop distance) and
QT duration. These ECG metrics in patients with SAI QRST in
the highest quartile and in 3 lower quartiles were compared by t-
test. Kaplan-Meier survival analysis was used to test the predictive
value of SAI QRST quartiles for SCD/VT/VF and all-cause
mortality. The univariate Cox regression analysis was performed
with SAI QRST as a continuous variable, and SAI QRST
dichotomized at the 75th percentile. Multivariable Cox regression
analyses were performed to adjust for clinical and demographic
variables associated with endpoints in the MADIT II study as
shown previously (age .70 years, blood urea nitrogen (BUN)
.25 mg/dl, New York Heart Association (NYHA) heart failure
(HF) class .II, QRS .120 ms, BBB status). Interaction between
SAI QRST and BBB status, as well as between SAI QRST and
study arm (ICD vs. conventional therapy) was tested in Cox
regression models for SCD/VT/VF and all-cause mortality.
Treatment-by-interaction term analysis was employed to evaluate
the benefit of the ICD in patients with the highest quartile of SAI
QRST and in those within the 3 lower quartiles of SAI QRST. A
P-value of ,0.05 was considered significant. SAS 9.2 (SAS
Institute Inc, Cary, NC) was used for data analysis.
Results
Study Population
Only patients with available baseline orthogonal ECGs were
included in this analysis. Baseline orthogonal ECGs of 796
MADIT II participants were reviewed. We excluded 32 ECG
recordings due to noise, 7 ECGs due to coarse atrial fibrillation, 4
ECGs due to frequent PVCs, 3 ECGs due to ventricular pacing,
and the remaining 750 ECGs were analyzed. Out of 750 analyzed
patients, 448 (59.7%) had an ICD implanted and 302 (40.3%)
received conventional medical therapy. Right BBB was present in
46(6.1%) patients, left BBB in 123(16.4%) patients and atrial
fibrillation in 7 (9.3%) patients. During follow-up, 104 patients
(23%) experienced appropriate ICD therapies, 48 patients (6.4%)
had SCD, and 26 patients (3.5%) had non-sudden cardiac death.
Figure 2. Correlation between the time after myocardial infarction and SAI QRST. P = 0.003.
doi:10.1371/journal.pone.0051812.g002
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ECG Characteristics of Adverse Electrical Remodeling and
SAI QTST
Patients in the highest quartile of SAI QRST (.334 mV*ms)
had significantly wider QRS with predominantly left BBB pattern;
they were older and had a higher occurrence of elevated BUN
level (Table 1). Wide QRS, prolonged QTc, significantly larger
magnitudes of spatial QRS and T vectors, and twice larger
amplitude of J-point deviation characterized ECG pattern of
adverse electrical remodeling in patients with SAI QRST in the
highest quartile (Table 2). SAI QRST strongly correlated with
QRS width (r = 0.634; p,0.0001; Figure 1A), mean magnitude of
spatial QRS vector (r = 0.662; p,0.0001; Figure 1B) and mean
magnitude of spatial T vector (r = 0.830; p,0.0001; Figure 1C).
All together depolarization characteristics (mean QRS duration
and mean magnitude of spatial QRS vector) accounted for three
quarters of the variance in SAI QRST (R2 = 0.75; p,0.0001).
Repolarization characteristics collectively (mean QT interval, J-
point deviation amplitude, measured as interloop distance, mean
magnitude of spatial T vector) accounted for approximately three
quarters of the variance in SAI QRST (R2 = 0.74; p,0.0001) as
well. In bivariate linear regression analysis, mean magnitude of
spatial T vector accounted for 69% of the variance in SAI QRST
value (R2 = 0.69; p,0.0001), whereas mean magnitude of spatial
QRS vector accounted for only 44% of the variance in SAI QRST
value (R2 = 0.44; p,0.0001). In contrast to magnitudes, impact of
intervals on SAI QRST in bivariate linear regression analysis was
smaller and varied from 40% for QRS width (R2 = 0.40;
p,0.0001) to 2% for QT interval (R2 = 0.02; p,0.0001).
Interestingly, in bivariate regression analysis, 25% of SAI QRST
variance was due to J-point deviation amplitude (R2 = 0.25;
p,0.0001). No meaningful correlation between mean heart rate
and SAI QRST was observed (Figure 1D).
SAI QRST and Clinical Characteristics of Patients
Patients with the SAI QRST in the highest quartile were older,
had lower body mass index (BMI), wider QRS and more likely had
left BBB (Table 1). Interestingly, they were more likely to have a
history of revascularization procedures and of recent MI (,18
months ago) and were more often on calcium channels antagonists
and diuretics, but were less often on beta-blockers.
During study follow-up patients with the highest quartile of SAI
QRST had about twice the rate of appropriate ICD therapies due
to sustained VT/VF, and at the same time about twice the rate of
non-sudden cardiac death and hospitalizations due to heart failure
exacerbations, as compared to patients with SAI QRST in 3 lower
quartiles (Table 2).
Time after Myocardial Infarction and SAI QRST
SAI QRST correlated with time after MI (Figure 2). Statistically
significant (P = 0.003) non-linear relationship is noticeable: the
largest SAI QRST was observed during the first 3 months after
MI. At the same time, a positive correlation was observed after 3
months in the post MI period.
Survival Analysis: Predictive Value of SAI QRST
Kaplan-Meier analysis showed statistically significant ‘‘dose-
dependent’’ pattern of relationship between SAI QRST and
SCD/VT/VF (Figure 3A): the larger SAI QRST the higher the
risk. Probability of VT/VF/SCD was about twice higher amongst
patients with SAI QRST in the highest quartile as compared to
patients with SAI QRST in the 3 lower quartiles (Figure 3B).
Importantly, large SAI QRST was associated with high risk of
ventricular arrhythmia in both the ICD arm and in the
conventional medical therapy arm (Figure 4A), although its
predictive value was especially remarkable in the ICD arm, due
to more frequent VT/VF events treated by ICD as compared to
SCD cases in conventional medical therapy arm (Table 2).
However, prediction of all-cause mortality by SAI QRST was
more noticeable in the conventional medical therapy arm, rather
than in the ICD arm (Figure 4B). Kaplan-Meier analysis survival
curves showed a time-dependent pattern of all-cause mortality,
which increased after 18 months of follow-up and possibly
reflected increased non-sudden cardiac death due to heart failure
progression, rather than complications of repeated acute coronary
events (Table 2). Interestingly, SAI QRST seemed predictive for
non-sudden cardiac death in both ICD arm and conventional
medical therapy arm (Figure 4B).
In the multivariable Cox proportional-hazards regression
model, after adjustment for other predictors of MADIT II study
outcomes (age, BUN, QRS duration, atrial fibrillation, NYHA
Figure 3. Kaplan-Meier curves for the probability of sudden arrhythmic death, (A) by quartiles of SAI QRST; (B) in patients with the
highest SAI QRST quartile and those with the lower 3 SAI QRST quartiles.
doi:10.1371/journal.pone.0051812.g003
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functional class), SAI QRST was an independent predictor of
SCD/VT/VF and all-cause death (Table 3). Multivariable Cox
model showed that increase in SAI QRST by 100 mV*ms would
result in a 33% increase in the risk of SCD/VT/VF and a 27%
increase in the risk of all-cause death.
SAI QRST and Bundle Branch Block
No interaction between SAI QRST and BBB status was
observed in multivariable Cox regression model (p = 0.987), and
SAI QRST predicted SCD/VF/VF (Figure 5A) and all-cause
mortality (Figure 5B) in patients with and without BBB.
Interestingly, in the subgroups analysis SAI QRST predicted
SCD/VT/VF in BBB patients, but all-cause death (predominantly
non-sudden cardiac death) in non-BBB patients (Table 4).
Discussion
Our study showed that SAI QRST quantifies adverse electrical
remodeling post-MI, which is characterized by wide QRS,
increased magnitudes of spatial QRS and spatial T vectors, J-
point deviation, and QT prolongation. We found that in MADIT
II post-MI patients with and without BBB, increased SAI QRST
independently predicted both VT/VF/SCD and all-cause death,
in both the ICD arm and the conventional medical therapy arm.
Enlarged SAI QRST was associated with increased risk after
adjustment for all composites of the MADIT II risk score (age .70
y, BUN.25 mg/dL, QRS duration .120 ms, NYHA HF
class.II, atrial fibrillation). Importantly, increased SAI QRST
predicted outcomes in patients with and without BBB. This study
showed that enlarged SAI QRST was associated with increased
Figure 4. Kaplan-Meier curves for the probability of (A) sudden arrhythmic death, and (B) all-cause mortality in patients with the
highest SAI QRST quartile and those with the lower 3 SAI QRST quartiles, by MADIT II study arm (ICD arm and conventional
medical therapy arm).
doi:10.1371/journal.pone.0051812.g004
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risk of sustained VT/VF, as well as non-sudden cardiac death and
HF hospitalizations, but not hospitalizations due to recurrent MI
(Table 2). Thus, the major finding of our study is that adverse
electrical remodeling as quantified by increased SAI QRST carries
independent risk of ventricular tachyarrhythmias, HF progression,
and non-sudden cardiac death in post-MI patients with systolic
dysfunction.
SAI QRST as a Marker of Adverse Electrical Remodeling
Post-MI
We proposed SAI QRST as a metric, which quantifies post-MI
electrical remodeling. Previous experimental and clinical studies
showed development of structural remodeling post-MI [6],
characterized by dilatation and distortion of LV cavity shape,
apoptosis, thinning, fibrosis and hypertrophy of remote from
infarction sites [6,7], scar formation and gradual remodeling of the
scar [4] in the central and border zone areas [5], dilatation of LV
cavity and/or other heart chambers, activation of the neurohu-
moral pathways, and left ventricular (LV) systolic and diastolic
dysfunction. Larger infarcts tend to show greater increases in cell
size in the non-infarcted areas, compared to smaller infarcts [7].
Development of regional hypertrophy post-MI is associated with
enhanced regional heterogeneity of repolarization and steeper
local gradient in spatial dispersion of repolarization, which is a
well-known substrate vulnerable to ventricular arrhythmias.
Complex structural and electrical remodeling post-MI result in a
slowing and fractionation of ventricular conduction, dispersion of
repolarization, occurrence of delayed afterdepolarizations [26]
and create conditions for reentry and arrhythmogenesis [27]. LV
hypertrophy is a strong, independent predictor of future cardio-
vascular events and SCD [28–30].
In addition, hibernating myocardium is characterized by
regional myocyte hypertrophy as well [31]. Altered calcium
uptake in the sarcoplasmic reticulum, inhomogeneity in sympa-
thetic activation, and increase in interstitial connective tissue might
lead to extremely high risk of SCD [31]. Despite significant
functional improvement of hibernating myocardium after revas-
cularization, inhomogeneity in myocardial sympathetic innerva-
tions might persist [32]. Thus, increased SAI QRST might be a
marker of hibernating myocardium or residual structural remod-
eling, persisting after revascularization. Further studies are needed
to test this hypothesis.
Importantly, as the MADIT II study included post-MI patients
only, results of this study should not be simply extrapolated on
other populations. Further studies are needed to answer the
question if SAI QRST is predicting electrical remodeling in the
ventricles with different underlying pathophysiology.
Ultimately post-MI remodeling of cardiac structure is charac-
terized [33] by changes in (1) cell geometry (size and shape), (2)
gap junctions (distribution and conductivity), and (3) interstitial
space (size and distribution). These changes could result in
increased curvature of the wavefront [34] and significant regional
slowing of conduction. Slowing of conduction is a fundamental
condition for reentrant circuit: the lower the conduction velocity,
the smaller the area in which a reentrant circuit can occur [35].
In our study, the largest SAI QRST was observed in patients
with recent MIs (,3 month, Figure 2), when hypertrophy had not
been developed yet. We speculate that the Brody effect is
responsible for significantly enlarged SAI QRST in early (,3
months) post-MI adverse remodeling. The Brody effect explains
that heart dipoles oriented perpendicular to the assumed spherical
border zone between high- and low- conductance layers are
effectively enhanced, resulting in larger surface potentials [36]. On
the other hand, those dipoles tangential to the high-low
conductivity tissue border are effectively diminished, resulting in
lowered surface potentials [37]. Progressive enlargement of the
infarcted ventricle and thinning and distension of the LV cavity
can result in a near-spherical shape of LV and elicit the Brody
effect on the blood-tissue border. Future theoretical studies are
needed to prove this hypothesis.
Correlation between the Time after Myocardial Infarction
and SAI QRST
Obviously, multiple confounding factors (age of patient, size of
the scar, preexisting LVH and other significant factors, listed in
Table 1) affect the significant nonlinear relationship between the
time after MI and SAI QRST. However, all these factors taken
together helped to reconcile SAI QRST as possibly being a time-
dependent marker of post-MI electrical remodeling. Prospective
longitudinal study is needed to prove this hypothesis.
Contradictory Findings in SAI QRST
Surprisingly, in our previous preliminary analysis of an ongoing
prospective study of patients with primary prevention ICD
Table 3. Hazard ratios for MADIT II risk score components for sudden arrhythmic death and all-cause mortality.
SCD/VT/VF Total mortality
Predictor Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Without SAI QRST NYHA CHF class .II 1.58(1.12–2.23) 0.009 1.67 (1.11–2.52) 0.014
Atrial fibrillation 3.43(0.84–14.05) 0.087 3.26(0.45–23.72) 0.244
QRS .120 ms 1.40(0.99–1.98) 0.060 1.61(1.07–2.41) 0.023
Age .70yrs 1.07(0.73–1.57) 0.736 2.10(1.38–3.18) 0.001
BUN .25 mg/dL 1.29(0.88–1.89) 0.186 1.98(1.30–3.02) 0.002
With SAI QRST NYHA CHF class .II 1.57(1.11–2.21) 0.011 1.22(0.75–1.98) 0.419
Atrial fibrillation 3.47(0.85–14.26) 0.084 3.42(0.47–24.99) 0.225
QRS .120 ms 1.01(0.66–1.53) 0.977 2.00(1.31–3.06) 0.001
Age .70y 1.00(0.67–1.47) 0.92 1.98(1.30–3.02) 0.002
BUN .25 mg/dL 1.28(0.87–1.87) 0.212 1.66(1.10–2.51) 0.015
SAI QRST per 100 mV*ms 1.33(1.11–1.59) 0.002 1.27(1.03–1.55) 0.022
doi:10.1371/journal.pone.0051812.t003
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diminished, but not increased SAI QRST was associated with
increased risk of VT/VF with appropriate ICD therapies [17,18].
Our data were obtained in somewhat different patients popula-
tions. In our earlier study patients with both ischemic and non-
ischemic cardiomyopathy were enrolled, whereas MADIT II
enrolled post-MI patients only. More females and African-
Americans were included in our prior study. Differences with
current data can be ascribed to these differences in studied
populations, but importantly, SAI QRST was a strong, indepen-
dent predictor of outcomes in both, independently performed,
studies. We currently can only speculate on the underlying
mechanism. One possible explanation came from modeling
studies, which showed that LV hypertrophy could be presented
by both diminished and increased magnitudes of spatial QRS and
T vector [38,39]. It is possible that different underlying
pathophysiology might result in a different pattern of SAI QRST
changes. Specifically, differences in the activation distribution and
in the heart and body surface geometry can be due to underlying
pathophysiology. This hypothesis is indirectly supported by the
experimental studies, which identified signaling pathways, affect-
ing some, but not all features of remodeling in different disease
models [16,40]. Further theoretical and clinical studies are needed
to clarify this intriguing discrepancy. Future large population
studies might help to detect U-shaped risk associated with SAI
QRST.
Risk Stratification in Post-MI Patients with BBB
Analysis of ECG in BBB is challenging and frequently
inconclusive. Therefore, our finding of strong, independent
predictive value of SAI QRST in BBB patients is clinically
important and promising. In this study, SAI QRST predicted
outcomes after adjustment for BBB status and QRS duration.
Figure 5. Kaplan-Meier curves for the probability of (A) sudden arrhythmic death, and (B) all-cause mortality in patients with the
highest SAI QRST quartile and those with the lower 3 SAI QRST quartiles, by the presence of bundle brunch block.
doi:10.1371/journal.pone.0051812.g005
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Interestingly, in BBB patients, increased SAI QRST more strongly
predicted sustained VT/VF events with appropriate ICD thera-
pies, rather than mortality. At the same time in patients without
BBB, SAI QRST predicted mortality rather than appropriate ICD
therapies.
ECG Predictors of Outcomes in MADIT II
Multiple ECG markers of SCD risk have been tested in MADIT
II data analysis, but only a few demonstrated independent
predictive value after adjustment for clinical predictors of
outcomes. Increased repolarization lability (QT variability and T
wave variability) has been shown to be significant, independent
predictor of appropriate ICD therapies in the ICD arm
[21,41,42], but did not predict SCD in the conventional medical
therapy arm. Frequent ventricular premature beats (.3/10 min)
were associated with death in the conventional medical therapy
arm and with appropriate ICD therapy in the ICD arm [43],
whereas heart rate turbulence was not predictive. In post-MI
patients with resolved Q waves, fragmented QRS was associated
with increased risk of cardiac events [44], but was not associated
with cardiac death independently of Q waves. Prolonged QRS
duration predicted SCD in the conventional medical therapy arm
[45], but did not predict VT/VF/SCD in the ICD arm. Thus far,
SAI QRST seems to be the only ECG predictor of both VT/VF/
SCD and total mortality in both MADIT II arms, which
underscores the importance of post-MI adverse electrical remod-
eling in the pathogenesis of arrhythmia and heart failure
progression.
Limitations
This was a retrospective analysis of prospectively collected data
of randomized controlled trial MADIT II, and, therefore,
statistical power of subgroups analysis was limited. Patients
without an available ECG have been excluded from this analysis.
However, absence of statistically significant interaction between
SAI QRST and BBB status in the Cox model suggests a similar
effect of SAI QRST on survival in patients with and without BBB.
Validation of predictive value of SAI QRST in a prospective study
is needed before its implementation into clinical practice.
As previously shown, appropriate ICD therapies may overes-
timate the frequency of SCD [45]. However, study of the
predictors of ventricular arrhythmia is critical for understanding
SCD mechanisms and developing mechanistically- sound risk
markers of SCD.
As MADIT II study population is predominantly presented by
white males, we did not apply race- and gender-specific thresholds
for SAI QRST in this study. At the same time, voltage ECG
parameters are known to be gender-specific [46] and further
development of gender- and possibly race-specific thresholds of
SAI QRST will be needed in the future.
SAI QRST is significantly different in patients with BBB as
compared to those without BBB [18]. Therefore, threshold of SAI
QRST that is specific for ventricular conduction status might
demonstrate better precision in prediction of outcomes. However,
in this study we utilized one uniform threshold of SAI QRST for
patients with and without BBB to simplify its implementation.
In this study only baseline ECGs were analyzed. Longitudinal
changes in SAI QRST over post-MI time course in correlation
with longitudinal changes in LV morphology, assessed by imaging,
are unknown. Future theoretical and prospective longitudinal
clinical studies are needed to confirm whether or not SAI QRST is
indeed a marker of electrical remodeling.
Conclusions
Adverse electrical remodeling as quantified by increased SAI
QRST carries independent risk of ventricular tachyarrhythmias,
HF progression and non-sudden cardiac death in post-MI patients
with systolic dysfunction. In post-MI MADIT II patients with and
without BBB, increased SAI QRST independently predicted both
VT/VF/SCD and all-cause death, both in the ICD arm and in
the conventional medical therapy arm. Enlarged SAI QRST was
associated with increased risk after adjustment for all composites of
the well-known MADIT II risk score (age .70 y, BUN.25 mg/
dL, QRS duration .120 ms, NYHA HF class.II, atrial
fibrillation).
Clinical Implications
The development of our novel ECG marker of adverse electrical
remodeling, SAI QRST, and demonstration of its predictive value
for SCD/VT/VF and all-cause mortality in a blinded analysis of
landmark ICD trial MADIT II opens up new opportunities for
SCD risk stratification. Future studies of SAI QRST are
warranted and might uncover novel mechanisms of electrical
remodeling in the post-infarction period.
Table 4. Multivariate Cox regression models for prediction of sudden arrhythmic death and all-cause mortality with SAI QRST as
continuous variable in patients with and without bundle branch block.
SCD/VF/VF Total mortality
Predictor Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
All patients BUN, mg/dL 1.02(1.00–1.03) 0.042 1.04(1.02–1.05) ,0.001
CHF NYHA class.II 1.61(1.10–2.34) 0.013 1.12(0.73–1.71) 0.604
SAI QRST per 100 mV*ms 1.30(1.09–1.56) 0.004 1.25(1.02–1.52) 0.029
Bundle branch block 0.95(0.60–1.49) 0.808 1.40(0.85–2.31) 0.184
BBB patients BUN, mg/dL 1.01(1.00–1.03) 0.049 1.04(1.02–1.05) ,0.001
CHF NYHA class.II 1.62(1.11–2.36) 0.012 1.13(0.74–1.74) 0.573
SAI QRST per 100 mV*ms 1.30(1.04–1.63) 0.020 1.17(0.78–1.73) 0.450
Non-BBB BUN, mg/dL 1.01(1.00–1.03) 0.049 1.04(1.02–1.05) ,0.001
CHF NYHA class.II 1.62(1.11–2.36) 0.012 1.13(0.74–1.74) 0.573
SAI QRST per 100 pmV*ms 1.31(0.96–1.77) 0.088 1.28(1.02–1.61) 0.035
doi:10.1371/journal.pone.0051812.t004
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